CEO SUMMARY: With new Congressional authorization and funding of $48 billion, PEPFAR II—a second five-year initiative to help targeted countries battle HIV, AIDs, tuberculosis, and malaria—is about to get under way. To better support diagnosis and management of HIV/AIDs patients, some PEPFAR funds are designated to expand laboratory testing services in countries with high prevalence
ASCP Awarded PEPFAR II Funds for Lab Assistance
By Robert Michel, from the Volume XVI No. 1 - January 12, 2009 issue